Exicure, Inc. Common Stock

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results. FMC posted adjusted earnings of $1.07 per share, missing market estimates of $1.08 per share. The company’s quarterly sales came in at $1.15 billion versus expectations of $1.25 billion. FMC shares dipped 9.8% to $54.51 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) jumped 144.4% to $0.5427 after dipping around 26% on Monday. Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 96% to $17.13 after the company announced the USPTO granted notice of allowance for the U.S. patent application "Levosimendan For Treating Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction." Agrify Corporation (NASDAQ: AGFY) shares climbed 70.1% to $1.0889. Agrify achieved milestone with PX-30 hydrocarbon extraction system installation in Michigan Facility. ADDvantage Technologies Group, Inc. (NASDAQ: AEY) gained 36% to $0.4769. Palantir Technologies Inc. (NYSE: PLTR) shares surged 27% to $21.23 after the company reported better-than-expected fourth-quarter sales results and issued guidance. Zenvia Inc. (NASDAQ: ZENV) rose 25% to $1.4621. Zenvia announced agreements to address funding gap and introduced EBITDA guidance for 2024, with a range between BRL 120 million and BRL140 million. Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 24% to $8.80. Helius Medical Technologies announced alignment with the FDA on registrational program for treatment of stroke patients. Exicure, Inc. (NASDAQ: XCUR) gained 21.7% to $0.67 after the company announced it entered ...

Related tickers: SYM, PRSO, NYCB, PEGY, CHGG, REBN, AEY, SUNW, GEHC, AMKR, KE, SGMT, COHR, TENX, CISS, CWCO, HSDT, GRDI, RMBS, TPET, CCK, SPOT, FMC, XCUR, IHS, TM, PLTR, UBS, AGFY, ST, ULCC, FN, ZENV, NVIV, NYXH, BRTX, JSPR.

Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance. Palantir said fourth-quarter revenue increased 20% year-over-year to $608 million, which beat the consensus estimate of $602.41 million, according to Benzinga Pro. Palantir reported quarterly adjusted earnings of 8 cents per share, which was in line with analyst estimates. Palantir expects first-quarter revenue to be between $612 million and $616 million versus estimates of $617.21 million. First-quarter adjusted income from operations is expected to be between $196 million and $200 million. Palantir Technologies shares jumped 18.2% to $19.77 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) gained 54.2% to $0.3424 in pre-market trading after dipping around 26% on Monday. Chenghe Acquisition Co. (NASDAQ: CHEA) shares jumped 43.2% to $10.08 in pre-market trading. Chenghe Acquisition shares jumped 28% on Monday after shareholders on Friday voted to approve the merger agreement with Taiwan Color Optics, Inc. Exicure, Inc. (NASDAQ: XCUR) gained 36.2% to $0.75 ...

Related tickers: NYXH, PRSO, RMBS, CHEA, SGMO, GRRR, FMC, CISS, ELAB, NVIV, SYM, NSTG, CHGG, TPET, AIRG, XCUR, CRKN, SOS, PLTR, RBOT.